Vladimir Hanes

Vladimir Hanes

UNVERIFIED PROFILE

Are you Vladimir Hanes?   Register this Author

Register author
Vladimir Hanes

Vladimir Hanes

Publications by authors named "Vladimir Hanes"

Are you Vladimir Hanes?   Register this Author

28Publications

611Reads

34Profile Views

Totality of evidence in the development of ABP 215, an approved bevacizumab biosimilar.

Immunotherapy 2019 10 26;11(15):1337-1351. Epub 2019 Sep 26.

Biosimilars Business Unit, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2019-0125DOI Listing
October 2019

Biosimilars: what the oncologist should know.

Future Oncol 2019 Apr 22;15(10):1147-1165. Epub 2019 Feb 22.

Public Health Sciences and Research Divisions, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0728DOI Listing
April 2019

Phase 3 LILAC study sets standard for clinical evaluation of oncology biosimilars.

Oncotarget 2019 Jan 1;10(1):8-9. Epub 2019 Jan 1.

Hans-Christian Kolberg: Marienhospital Bottrop gGmbH, Bottrop, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343751PMC
January 2019

Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men.

Cancer Chemother Pharmacol 2018 02;81(2):419

Biosimilars Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3457-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778164PMC
February 2018

A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men.

Cancer Chemother Pharmacol 2017 Oct 1;80(4):755-763. Epub 2017 Sep 1.

Biosimilars Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-017-3416-4
Publisher Site
http://dx.doi.org/10.1007/s00280-017-3416-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696486PMC
October 2017

A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects.

Cancer Chemother Pharmacol 2017 May 24;79(5):881-888. Epub 2017 Mar 24.

Biosimilars Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-017-3286-9
Publisher Site
http://dx.doi.org/10.1007/s00280-017-3286-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403841PMC
May 2017

Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.

Menopause 2014 Jun;21(6):633-40

From the 1Women's Health and Research Consultants, George Washington University School of Medicine, Washington, DC; 2University Hospitals Case Medical Center, Cleveland, OH; 3Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT; and 4Boehringer Ingelheim Pharma GmbH and Co KG, Ingelheim, Germany.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/GME.0000000000000134DOI Listing
June 2014

Effects of the hormone therapy, drospirenone and 17-beta estradiol, on early morning blood pressure in postmenopausal women with hypertension.

J Am Soc Hypertens 2008 Jan-Feb;2(1):20-7

Division of Hypertension and Clinical Pharmacology, The Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S193317110700171
Publisher Site
http://dx.doi.org/10.1016/j.jash.2007.08.004DOI Listing
October 2012

Evaluation of the Sexual Desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder.

J Sex Med 2012 May 29;9(5):1344-54. Epub 2012 Feb 29.

Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-6109.2012.02679.xDOI Listing
May 2012

Content validity of the Female Sexual Function Index (FSFI) in pre- and postmenopausal women with hypoactive sexual desire disorder.

J Sex Med 2011 Aug 19;8(8):2237-45. Epub 2011 May 19.

Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-6109.2011.02312.xDOI Listing
August 2011

The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women.

Am J Obstet Gynecol 2008 Mar;198(3):265.e1-7

Department of Medicine, University of California San Francisco School of Medicine, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000293780701183
Publisher Site
http://dx.doi.org/10.1016/j.ajog.2007.09.039DOI Listing
March 2008

Drospirenone, a new progestogen, for postmenopausal women with hypertension.

Drugs Aging 2007 ;24(6):453-66

Division of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut 06030-3940, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00002512-200724060-00002DOI Listing
August 2007

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.

Menopause 2007 May-Jun;14(3 Pt 1):408-14

Division of Clinical Pharmacology and Pharmacokinetics Clinical Research Center, Department of Medicine, Miller School of Medicine, University of Miami, FL 33136, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00042192-200714030-000
Publisher Site
http://dx.doi.org/10.1097/01.gme.0000243572.63322.f7DOI Listing
July 2007

Comparison of methods to measure low serum estradiol levels in postmenopausal women.

J Clin Endocrinol Metab 2006 Oct 1;91(10):3791-7. Epub 2006 Aug 1.

San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA 94107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2005-2378DOI Listing
October 2006

Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.

Hypertension 2006 Aug 26;48(2):246-53. Epub 2006 Jun 26.

Division of Hypertension and Clinical Pharmacology, The Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, 263 Farmington Ave, Farmington, CT 06030-3940, USA.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/01.HYP.0000232179.60
Publisher Site
http://dx.doi.org/10.1161/01.HYP.0000232179.60442.84DOI Listing
August 2006

Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.

Menopause 2006 Jan-Feb;13(1):130-8

Department of Medicine, University of Minnesota, Minneapolis, 55415, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.gme.0000192439.82491.24DOI Listing
April 2006

Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.

Circulation 2005 Sep;112(13):1979-84

Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT 06030-3940, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.104.501502DOI Listing
September 2005

Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.

Am J Hypertens 2005 Jun;18(6):797-804

Division of Clinical Pharmacology and Pharmacokinetics Clinical Research Center, Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjhyper.2004.12.003DOI Listing
June 2005